TransCode Therapeutics Inc. Gains 45.45%
Fri, Mar 21, 2025 at 07:43 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) shot up at $1.12, representing a gain of 45.5%. On Fri, Mar 21, 2025, RNAZ:NASDAQ touched a New 2-Week Intraday High of $1.67. The stock got featured on our News Catalysts scanner on Fri, Mar 14, 2025 at 10:45 AM in the 'MISCELLANEOUS' category. From Fri, Mar 07, 2025, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Mar 21, 2025 at $1.67 with a volume of 214M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Sacks Parente Golf Inc. (SPGC:NASDAQ), 2042.86%
- Smart for Life Inc. (SMFL:NASDAQ), 255.36%
- Singularity Future Technology Ltd. (SGLY:NASDAQ), 143.44%
- IBO (Listing Market - NYSE Amex (IBO:NYSEMKT), 138.46%
- Allurion Technologies Inc. (ALUR:NYSE), 57.02%
- VivoPower International PLC (VVPR:NASDAQ), 52.14%
- Galecto Inc. (GLTO:NASDAQ), 45.58%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 45.45%
- TEN Holdings Inc. (XHLD:NASDAQ), 40.37%
- Click Holdings Limited (CLIK:NASDAQ), 34.63%